Columbia University Medical Center HEAL and HEALTH

Total Page:16

File Type:pdf, Size:1020Kb

Columbia University Medical Center HEAL and HEALTH ANNUAL REPORT 2004–2005 heal Columbia University Medical Center HEAL AND HEALTH. THOSE INTERDEPENDENT CONCEPTS, SO CLOSELY LINKED THAT THEY ARE NEARLY THE SAME WORD, LIE AT THE HEART OF THE MISSION OF COLUMBIA UNIVERSITY’S COLLEGE OF PHYSICIANS & SURGEONS. ONE OF THE EARLIEST FACTS A YOUNG DOCTOR-TO-BE LEARNS Contents Dean’s Letter 2 DURING MEDICAL SCHOOL IS THAT THE BODY IS ORGANIZED INTO Human System 4 SYSTEMS—CARDIOVASCULAR, RESPIRATORY, NERVOUS, MUSCULO- Nervous System 8 SKELETAL, AND SO ON—THAT WORK IN AN INTEGRATED WAY TO Immune System 15 KEEP THAT BODY HEALTHY AND FUNCTIONING. WHEN THE Respiratory System 19 INTEGRATED SYSTEMS OF THE HUMAN BODY WORK PROPERLY Cardiovascular System 22 Systems of Education and Care 28 TOGETHER, WE HAVE HEALTH. WHEN THESE SYSTEMS FALTER, WE Dedication 32 MUST HEAL. College of Physicians & Surgeons 33 THIS YEAR’S ANNUAL REPORT FOCUSES ON COLUMBIA’S Development 34 Generous Donors 37 ACHIEVEMENTS DURING 2004 AND 2005 THROUGH THE PRISM OF In Memoriam 43 THE BODY’S INTEGRATED SYSTEMS. AT THE SAME TIME, WE EXAM- Financial Highlights 44 INE COLUMBIA’S ESSENTIAL ROLE TO PROMOTE HEALING AND Trustees Committee of the ADVANCE HEALTH IN THE “SYSTEM” OF OUR LOCAL COMMUNITY Health Sciences 46 Advisory Council 46 AND THE WIDER WORLD. Administration 46 Executive Committee of the Faculty Council 47 Department Chairs 47 Interdepartmental Centers 48 Departmental Centers 48 Affiliated Hospitals 50 From the Dean The role of a great medical center is to strategies to prevent cancer from ever oc- promote health and healing in the broadest curring. context: from the development of new Few institutions have the financial and Gerald D. Fischbach, M.D. scientific concepts, to the isolation of new personnel resources to mount such a di- Executive Vice President candidate therapies, to the validation of new verse attack. At Columbia, thanks not Columbia University therapies via clinical research, to providing only to the recognition and support of the Medical Center Dean, Faculty of Medicine our patients with informed guidance in National Cancer Institute, but also to the using those therapies. Our efforts cut across generosity of Herbert and Florence Irving, traditional departmental boundaries to we have that capability. In May, we opened involve the entire medical center and, in the Irving Cancer Research Center, a 02 P&S ANNUAL REPORT 2004-05 many cases, the entire university, linking 300,000-square-foot facility in the Audubon DEAN’S LETTER * disciplines like biology and genetics with Biomedical Science and Technology Park, engineering and physics. located between the Russ Berrie Medical Here at Columbia University College of Science Pavilion and the Mary Woodard Physicians & Surgeons, this cross-cutting Lasker Biomedical Research Building. continuum is dramatically illustrated in Together, these facilities form nearly 700,000 our attempts to understand, treat, and square feet of dedicated research space. defeat cancer—which during the past year But research space means little without surpassed heart disease as the top killer of scientists to use it. This brings me to another Americans under the age of 85. Columbia’s reason for my great optimism about cancer This “comprehensive” approach serves and motivation. This is my own area of Irving Comprehensive Cancer Center research and care at Columbia: the appoint- as the model for what we hope to establish expertise and I look forward to helping out. (ICCC) is one of only three National Cancer ment of Riccardo Dalla-Favera as the new in other fields beyond cancer, fields rang- With our strategic interdepartmental Institute-designated comprehensive cancer director of the ICCC. A world-renowned ing from nervous system disorders to car- approach we can define the future of med- centers in New York state, and one of fewer researcher, Riccardo is also a talented diovascular disease to immunology and ical science and medical education. Our than 40 such centers in the nation. This clinician and administrator. His area of metabolic disorders. long-term goal must be to reduce suffering prestigious designation recognizes the expertise is in the molecular genetics of This model will form the basis for the and enable all people to lead full lives. Our depth and breadth of cancer research and lymphoma and other bloodborne cancers. new Center for Neuroscience Initiatives, immediate goal is to provide an environ- treatment available at P&S. At Columbia we Dr. Dalla-Favera’s task will be to expand which will be built around fundamental ment in which the best research can be span the entire spectrum, from basic our research enterprise, taking advantage of themes in the study of brain science: conducted and in which the very best of scientific understanding of mechanisms this extraordinary time in which we have a neurodegeneration, neural repair and plas- the next generation can be trained. that make cells divide out of control, invade deeper understanding of underlying causes ticity, cognition and behavior, and mood adjacent tissues, and metastasize widely of cancer. He will collaborate with our throughout the body. We are committed to clinical leaders in building a superb clinical the development of new treatments and new oncology program. Healing the Whole Though its origins may be isolated to one National Cancer Institute, the Institute for part of the body, cancer ultimately attacks Cancer Genetics will study the molecular the health of the entire human system if pathways that lead to the development of left untreated, metastasizing from the breast cancer, with the ultimate goal of de- breast to the lung, the prostate to the bone, veloping more targeted therapeutics like or the pancreas to the liver. This most the drug Herceptin. Herceptin is currently feared of diseases is, perhaps, the ultimate the only “rationally designed” drug available example of how the health of one human for breast cancer, selectively killing cancer system is inextricably tied to the health of cells by attaching to Her2 receptors while the whole. leaving healthy cells untouched. Since Her2 Over the past year, Columbia has been receptors are present in only 20 percent of P&S ANNUAL REPORT 2004-05 5 the human system HUMAN SYSTEM * laying the foundations for one of its most tumors, however, many more such drugs NERVOUS SYSTEM ambitious initiatives yet: the evolution of are needed, says Dr. Riccardo Dalla-Favera, IMMUNE SYSTEM RESPIRATORY SYSTEM the Irving Comprehensive Cancer Center, director of the institute and the grant’s CARDIOVASCULAR SYSTEM already a national leader in the field, into principal investigator. SYSTEMS OF EDUCATION AND CARE one of the world’s premier cancer Dr. Dalla-Favera, newly named as head programs. In scope and depth, in clinical of the Irving Comprehensive Cancer and basic science expertise, and in Center, will also lead investigators in a five- compassionate patient care, Columbia’s year, $5 million grant from the Leukemia cancer center will stand among the giants and Lymphoma Society as they test an ex- in the field. perimental lymphoma drug in clinical Two major grants are helping to drive trials. In partnership with Memorial the expansion of the cancer center. With a Sloan-Kettering Cancer Center, Columbia $15.5 million, five-year grant from the investigators will also study the mutations Robot scrubs in: Michael Treat, associate professor of clinical surgery, has developed a unique one-armed robotic scrub technician known as Penelope. Most surgical robots currently available are run by surgeons, but Penelope is a “stand-alone co-worker,” says Dr. Treat. Using machine vision—a digital camera that sees the surgical field, along with software that can identify instruments— Penelope “scrubbed in” on her first case in March 2005, part of a research study to vali- date that the robot is working as expected. that lead to lymphomas, the most common processes by which the genetic instructions production center in the Black Building. cancer among people 30 to 40 years old. encoded by the genome produce the tissues, The new Synthetic Organic Chemistry One of the most exciting approaches to organs, and behavior that make us human. Collaborative Center provides researchers understanding cancer and many other It won’t be easy: The human genome, which with experimental therapeutics and other disease mechanisms is known as chemical has about 25,000 genes, produces possibly molecules needed for their preclinical biology, or chemical genomics. This “big 200,000 different proteins—maybe as studies, molecules needed for the pilot science” strategy takes a high-throughput, many as 1 million proteins. This makes for studies that are essential to garnering grant systematic approach to chemistry and bi- an almost infinite variety of protein in- support for larger studies. ology so powerful that it can screen some teractions, or combinations of proteins Other new centers at Columbia will 50,000 chemical compounds against a single that drive a cell’s activities. Helping also tie research and treatment together in biological disease target in just one day, medicine take advantage of this vast, un- a comprehensive, multidisciplinary testing each of them to see how they act charted frontier of information in order to approach. One of these is the Reiner against the disease. But it’s not just a drug improve human health is the goal of Center for Behavioral and Psychosomatic development tool; it’s a process that may Columbia’s new Joint Center for Systems Medicine, the only center of its kind in help physicians at Columbia and elsewhere Biology. The center will use high-speed, New York City. It will explore how psychi- better understand how human disease— advanced computational tools to analyze atric, psychological, behavioral, and genetic 06 P&S ANNUAL REPORT 2004-05 and human healing—operates at the most an enormous database of 2.5 million factors affect human health and contribute * THE HUMAN SYSTEM NERVOUS SYSTEM basic cellular and molecular levels.
Recommended publications
  • The Creation of Neuroscience
    The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits.
    [Show full text]
  • Neuregulin Induces the Expression of Transcription Factors and Myosin Heavy Chains Typical of Muscle Spindles in Cultured Human Muscle
    Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle Christian Jacobson*, David Duggan†, and Gerald Fischbach‡§ *Microarray Unit, Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892; †Translational Genomics Research Institute (TGen), Phoenix, AZ 85004; and ‡Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY 10032 Contributed by Gerald Fischbach, June 29, 2004 Neuregulin (NRG) (also known as ARIA, GGF, and other names) is (DRG) (28), proprioceptive sensory neurons in particular, ex- a heparin sulfate proteoglycan secreted into the neuromuscular press NRG early in development (14, 29, 30). While these junction by innervating motor and sensory neurons. An integral experiments were ongoing, reports appeared implicating NRG in part of synapse formation, we have analyzed NRG-induced the development of muscle spindles. Hippenmeyer et al. (14) changes in gene expression over 48 h in primary human myotubes. showed that NRG induces the expression of early growth We show that in addition to increasing the expression of acetyl- response 3 (Egr3), a transcription factor that is critical to the choline receptors on the myotube surface, NRG treatment results differentiation of muscle spindle fibers (31). Evidence for NRG’s in a transient increase of several members of the early growth role in spindle formation is re-enforced by the phenotypic response (Egr) family of transcription factors. Three Egrs, Egr1, -2, similarities between conditional Erb2 knockout animals and and -3, are induced within the first hour of NRG treatment, with Egr3 null mice (13, 15, 24).
    [Show full text]
  • Making Your Mind: Molecules, Motion, and Memory Lecture One – Mapping Memory in the Brain Eric R
    Making Your Mind: Molecules, Motion, and Memory Lecture One – Mapping Memory in the Brain Eric R. Kandel, M.D. 1. Start of Lecture I (0:15) [ANNOUNCER:] From the Howard Hughes Medical Institute. The 2008 Holiday Lectures on Science. This year's lectures, "Making Your Mind: Molecules, Motion, and Memory," will be given by Dr. Eric Kandel, Howard Hughes Medical Institute investigator at Columbia University, and Dr. Thomas Jessell, Howard Hughes Medical Institute investigator also at Columbia University. The first lecture is titled "Mapping Memory in the Brain." And now to introduce our program, the President of the Howard Hughes Medical Institute, Dr. Thomas Cech. 2. Welcome by HHMI President Dr. Thomas Cech (1:08) [DR. CECH] Welcome to the Howard Hughes Medical Institute and the 2008 Holiday Lectures on Science. The Institute initiated this series in 1993. In 1995 I had the pleasure of coming here and delivering the lectures on catalytic RNA, and since I've been President of the Institute it's been a great pleasure to be involved in choosing 18 terrific scientists to talk to students here in the auditorium. The Holiday Lectures are one of more than 30 research and education programs of the Institute and please visit our website www.hhmi.org to learn more about all of our activities. This lecture series focuses on the most complex organ in our body and arguably the one that most is responsible for making us human. Clearly without this organ you wouldn't be able to find this auditorium, and even if you got here you wouldn't understand a word that was being said.
    [Show full text]
  • COLUMBIA Columbia University DIGITAL KNOWLEDGE VENTURES
    COLUMBIA columbia university DIGITAL KNOWLEDGE VENTURES Brain and Mind May 13, 2004 Gerald D. Fischbach, MD Neuroscience and Neuropathology—Converging Streams Introduction by Lee Bollinger President Lee Bollinger: This symposium is the result of the very, very hard work of Professor Tom Jessell and Dr. Joanna Rubinstein, and I want to thank and acknowledge them, and would like to thank all of you for coming. This is a great testament to the general perceived importance of the subjects of this symposium. I want to thank all the speakers who have come to participate. I want to take this occasion just to announce that Columbia will be launching—we are launching, as of this moment—an institute for neuroscience that will be part (eventually) of the major center for the study of the brain and behavior. We all, I think, recognize in the academy the extraordinary advances that have come just in the past few decades, the past decade in particular, because of the discoveries around the genetic code. Where that will take us of course we don't know, and we're making very, very significant investments across the country in trying to advance knowledge as a result of that new knowledge. But the study of the brain and how it works is clearly central not only to the curing of disease, but also to the understandings that we bring to every, virtually every, area of life: social sciences, the professions, and the humanities. And it is Columbia's goal to try to bring as many scientific advances as we possibly can to this area, and also to integrate it with other areas of knowledge.
    [Show full text]
  • Neuregulin and Erbb Receptors Play a Critical Role in Neuronal Migration
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neuron, Vol. 19, 39±50, July, 1997, Copyright 1997 by Cell Press Neuregulin and erbB Receptors Play a Critical Role in Neuronal Migration Carlos Rio,*³ Heather I Rieff,*²³ Peimin Qi,* the external germinal layer (EGL) and migrate inward and Gabriel Corfas*² along Bergmann radial fibers to their final destination, *Division of Neuroscience and Department the internal granule cell layer (IGL) (Rakic, 1971). In ro- of Neurology dents, this migration takes place during the first 2 post- Children's Hospital and Harvard Medical natal weeks. Granule cell migration has been studied School in vitro in both cerebellar slices and in cocultures of 300 Longwood Avenue dissociated cerebellar granule cells and astroglia. These ² Program in Neuroscience studies have implicated a number of molecules in steps Harvard Medical School of the migration process, for example, cell adhesion 220 Longwood Avenue molecules, i.e., AMOG (Antonicek et al., 1987; Gloor et Boston, Massachusetts 02115 al. 1990) and astrotactin (Zheng et al., 1996); ion chan- nels, i.e., NMDA receptors (Komuro and Rakic, 1993) and Ca21 channels (Komuro and Rakic, 1992). In addition, Summary studies of mutant mouse lines with defects in brain de- velopment have led to the identification of other mole- The migration of neuronal precursors along radial glial cules, including potassium channels in the case of the fibers is a critical step in the formation of the nervous weaver mutant (Rakic and Sidman, 1973; Patil et al., system. In this report, we show that neuregulin±erbB 1995); the extracellular matrix protein reelin in the reeler receptor signaling plays a crucial role in the migration mutant (Caviness and Sidman, 1973; D'Arcangelo et al., of cerebellar granule cells along radial glial fibers.
    [Show full text]
  • And Neuropeptide Y-Immunoreactive Neurons in Rat and Monkey Neocortex’
    0270.6474/84/0410-2497$02.00/O The Journal of Neuroscience Copyright 0 Society for Neuroscience Vol. 4, No. 10, pp. 2497-2517 Printed in U.S.A. October 1984 MORPHOLOGY, DISTRIBUTION, AND SYNAPTIC RELATIONS OF SOMATOSTATIN- AND NEUROPEPTIDE Y-IMMUNOREACTIVE NEURONS IN RAT AND MONKEY NEOCORTEX’ S. H. C. HENDRY,* E. G. JONES,*** AND P. C. EMSONS *James L. O’Leary Division of Experimental Neurology and Neurological Surgery and McDonnell Center for Studies of Higher Brain Function, Washington University School of Medicine, Saint Louis, Missouri 63110 and $ MRC Neurochemical Pharmacology Unit, Medical Research Council Centre, Hills Road, Cambridge CB2 2&H, England Received January 6,1984, Revised March 23,1934; Accepted March 30,1964 Abstract Neurons in the monkey and rat cerebral cortex immunoreactive for somatostatin tetradecapeptide (SRIF) and for neuropeptide Y (NPY) were examined in the light and electron microscope. Neurons immunoreactive for either peptide are found in all areas of monkey cortex examined as well as throughout the rat cerebral cortex and in the subcortical white matter of both species. In monkey and rat cortex, SRIF-positive neurons are morphologically very similar to NPY-positive neurons. Of the total population of SRIF-positive and NPY- positive neurons in sensory-motor and parietal cortex of monkeys, a minimum of 24% was immunoreactive for both peptides. Most cell bodies are small (8 to 10 pm in diameter) and are present through the depth of the cortex but are densest in layers II-III, in layer VI, and in the subjacent white matter. From the cell bodies several processes commonly emerge, branch two or three times, become beaded, and extend for long distances through the cortex.
    [Show full text]
  • Meeting Program SID 2019 ANNUAL MEETING
    Meeting Program SID 2019 ANNUAL MEETING 2019 Annual Meeting Scientific 2019 Annual Meeting Program Chairs, Committee Committee on Education Members, and Reviewers Chairs and Committee CHAIRS Members Dan Kaplan, MD/PhD, University of Pittsburgh CHAIRS Ethan Lerner, MD/PhD, Mass General Hospital Heidi Kong, MD, National Insitutes of Health Todd Ridky, MD/PhD, University of Pennsylvania COMMITTEE MEMBERS Lloyd Miller, MD/PhD, Johns Hopkins University COMMITTEE MEMBERS Kevin Wang, MD/PhD, Stanford University My Mahoney, PhD, Thomas Jefferson University Spiro Getsios, PhD, Aspect Biosystems Alexander Marneros, MD/PhD, Harvard University Peggy Myung, MD/PhD, Yale University Robert Dellavalle, MD/PhD, University of Colorado Marjana Tomic-Canic PhD, University of Miami Amanda MacLeod, MD, Duke University Vladimir Botchkarev, MD/PhD, Boston University Cristina de Guzman Strong, PhD, Washington University-St. Louis Tissa Hata, MD, University of California, San Diego Maryam Asgari, MD, Massachusetts General Hospital Ken Tsai, MD/PhD, Moffitt Cancer Center and Paul Nghiem, MD/PhD, University of Washington Research Institute Richard Granstein, MD, Weill Cornell Medical School Sarah Millar, PhD, Mt. Sinai Medical School Matthew Vesley, MD/PhD, Yale University REVIEWERS Anna Di Nardo, MD/PhD Jennifer Gill, MD/PhD, University of Texas Southwestern Carolyn Lee, MD/PhD Jonathan Silverberg, MD/PhD ACKNOWLEDGEMENTS Bogi Andersen, MD The organizers of the 2019 SID Annual Meeting gratefully Kavita Sarin, MD/PhD acknowledge the sponsors, exhibitors, and participants whose Peter Koch, PhD Tiffany C. Scharschmidt, MD attendance has helped to make this meeting possible. Joseph Merola, MD Sakeen Kashem, MD/PhD Thomas Hultsch, MD Amanda MacLeod, MD Liang Deng, MD/PhD Ya-Chieh Hsu, PhD Crystal Aguh, MD Katherine Radek, PhD Paul Nghiem, MD/PhD Alicia Mathers, PhD Raymond Cho, MD Zelma Chiesa, MD Anna Mandinova, MD/PhD Brian Capell, MD/PhD Ryan R.
    [Show full text]
  • Dynamics of Excitatory-Inhibitory Neuronal Networks With
    I (X;Y) = S(X) - S(X|Y) in c ≈ p + N r V(t) = V 0 + ∫ dτZ 1(τ)I(t-τ) P(N) = 1 V= R I N! λ N e -λ www.cosyne.org R j = R = P( Ψ, υ) + Mγ (Ψ, υ) σ n D +∑ j n k D k n MAIN MEETING Salt Lake City, UT Feb 27 - Mar 2 ................................................................................................................................................................................................................. Program Summary Thursday, 27 February 4:00 pm Registration opens 5:30 pm Welcome reception 6:20 pm Opening remarks 6:30 pm Session 1: Keynote Invited speaker: Thomas Jessell 7:30 pm Poster Session I Friday, 28 February 7:30 am Breakfast 8:30 am Session 2: Circuits I: From wiring to function Invited speaker: Thomas Mrsic-Flogel; 3 accepted talks 10:30 am Session 3: Circuits II: Population recording Invited speaker: Elad Schneidman; 3 accepted talks 12:00 pm Lunch break 2:00 pm Session 4: Circuits III: Network models 5 accepted talks 3:45 pm Session 5: Navigation: From phenomenon to mechanism Invited speakers: Nachum Ulanovsky, Jeffrey Magee; 1 accepted talk 5:30 pm Dinner break 7:30 pm Poster Session II Saturday, 1 March 7:30 am Breakfast 8:30 am Session 6: Behavior I: Dissecting innate movement Invited speaker: Hopi Hoekstra; 3 accepted talks 10:30 am Session 7: Behavior II: Motor learning Invited speaker: Rui Costa; 2 accepted talks 11:45 am Lunch break 2:00 pm Session 8: Behavior III: Motor performance Invited speaker: John Krakauer; 2 accepted talks 3:45 pm Session 9: Reward: Learning and prediction Invited speaker: Yael
    [Show full text]
  • As the Year 2008 Draws To
    FROM THE EDITORS s the year 2008 draws to a close, excitement and an expectation of change hang in the air, and not least in the field of neuroscience. “We have recently had a decade of the brain, and there is a sense that this will be a century of Aneuroscience,” says Pasko Rakic, one of three winners of this year’s Kavli prize for neuroscience, in an interview on page 893. Pasko Rakic, Sten Grillner and Thomas Jessell were recognized for their pioneering work and outstanding contributions to elucidating the development and function of neural circuits. This highly prestigious prize, which will be given biannually in the fields of nanoscience, neuroscience and astrophysics, was awarded ▶ cover: ‘Winter action’ by Kirsten Lee, inspired for the first time this year. The interviews highlight the milestones in the by the Perspective on p957. careers of the awardees, their outlook on neuroscience and their advice for young neuroscientists. This issue also marks the start of a new article series that will cover different aspects of sleep. On page 910, Krueger and colleagues review the accumulated evidence for the hypothesis that sleep is regulated locally through the induction of sleep-like states in individual cortical cLaudia wiedeMann katherine whaLLey columns and that synchronization of these states might lead to whole-animal sleep. Another timely subject, which we cover in this issue’s Science and Society article (page 957), is the rising rate of ADHD diagnosis in children. Ilina Singh discusses the science behind the current diagnostic criteria and Leonie weLberg Monica hoyoS fLight the ethical and social issues that arise from medicating young children.
    [Show full text]
  • Alumni Director Cover Page.Pub
    Harvard University Program in Neuroscience History of Enrollment in The Program in Neuroscience July 2018 Updated each July Nicholas Spitzer, M.D./Ph.D. B.A., Harvard College Entered 1966 * Defended May 14, 1969 Advisor: David Poer A Physiological and Histological Invesgaon of the Intercellular Transfer of Small Molecules _____________ Professor of Neurobiology University of California at San Diego Eric Frank, Ph.D. B.A., Reed College Entered 1967 * Defended January 17, 1972 Advisor: Edwin J. Furshpan The Control of Facilitaon at the Neuromuscular Juncon of the Lobster _______________ Professor Emeritus of Physiology Tus University School of Medicine Albert Hudspeth, M.D./Ph.D. B.A., Harvard College Entered 1967 * Defended April 30, 1973 Advisor: David Poer Intercellular Juncons in Epithelia _______________ Professor of Neuroscience The Rockefeller University David Van Essen, Ph.D. B.S., California Instute of Technology Entered 1967 * Defended October 22, 1971 Advisor: John Nicholls Effects of an Electronic Pump on Signaling by Leech Sensory Neurons ______________ Professor of Anatomy and Neurobiology Washington University David Van Essen, Eric Frank, and Albert Hudspeth At the 50th Anniversary celebraon for the creaon of the Harvard Department of Neurobiology October 7, 2016 Richard Mains, Ph.D. Sc.B., M.S., Brown University Entered 1968 * Defended April 24, 1973 Advisor: David Poer Tissue Culture of Dissociated Primary Rat Sympathec Neurons: Studies of Growth, Neurotransmier Metabolism, and Maturaon _______________ Professor of Neuroscience University of Conneccut Health Center Peter MacLeish, Ph.D. B.E.Sc., University of Western Ontario Entered 1969 * Defended December 29, 1976 Advisor: David Poer Synapse Formaon in Cultures of Dissociated Rat Sympathec Neurons Grown on Dissociated Rat Heart Cells _______________ Professor and Director of the Neuroscience Instute Morehouse School of Medicine Peter Sargent, Ph.D.
    [Show full text]
  • Annual Report 20 14
    ANNUAL REPORT 2014 HUMAN FRONTIER SCIENCE PROGRAM The Human Frontier Science Program is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is implemented by an international organisation, supported financially by Australia, Canada, France, Germany, India, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, Switzerland, the United Kingdom, the United States of America, and the European Union. Since 1990, over 6000 awards have been made to researchers from more than 70 countries. Of these, 25 HFSP awardees have gone on to receive the Nobel Prize. APRIL 2014 - MARCH 2015 ANNUAL REPORT — 3 — Table of contents The following documents are available on the HFSP web site www.hfsp.org: Joint Communiqués (Tokyo 1992, Washington 1997, Berlin 2002, Bern 2004, Ottawa 2007, Canberra 2010, Brussels 2013): http://www.hfsp.org/about-us/governance/intergovernmental-conference Statutes of the International Human Frontier Science Program Organization : http://www.hfsp.org/about-us/governance/statutes Guidelines for the participation of new members in HFSPO : http://www.hfsp.org/about-us/new-membership General reviews of the HFSP (1996, 2001, 2006-2007, 2010): http://www.hfsp.org/about-us/reviews-hfsp Updated and previous lists of awards, including titles and abstracts: http://www.hfsp.org/awardees — 4 — INTRODUCTION Introduction
    [Show full text]
  • Celebrating 40 Years of Rita Allen Foundation Scholars 1 PEOPLE Rita Allen Foundation Scholars: 1976–2016
    TABLE OF CONTENTS ORIGINS From the President . 4 Exploration and Discovery: 40 Years of the Rita Allen Foundation Scholars Program . .5 Unexpected Connections: A Conversation with Arnold Levine . .6 SCIENTIFIC ADVISORY COMMITTEE Pioneering Pain Researcher Invests in Next Generation of Scholars: A Conversation with Kathleen Foley (1978) . .10 Douglas Fearon: Attacking Disease with Insights . .12 Jeffrey Macklis (1991): Making and Mending the Brain’s Machinery . .15 Gregory Hannon (2000): Tools for Tough Questions . .18 Joan Steitz, Carl Nathan (1984) and Charles Gilbert (1986) . 21 KEYNOTE SPEAKERS Robert Weinberg (1976): The Genesis of Cancer Genetics . .26 Thomas Jessell (1984): Linking Molecules to Perception and Motion . 29 Titia de Lange (1995): The Complex Puzzle of Chromosome Ends . .32 Andrew Fire (1989): The Resonance of Gene Silencing . 35 Yigong Shi (1999): Illuminating the Cell’s Critical Systems . .37 SCHOLAR PROFILES Tom Maniatis (1978): Mastering Methods and Exploring Molecular Mechanisms . 40 Bruce Stillman (1983): The Foundations of DNA Replication . .43 Luis Villarreal (1983): A Life in Viruses . .46 Gilbert Chu (1988): DNA Dreamer . .49 Jon Levine (1988): A Passion for Deciphering Pain . 52 Susan Dymecki (1999): Serotonin Circuit Master . 55 Hao Wu (2002): The Cellular Dimensions of Immunity . .58 Ajay Chawla (2003): Beyond Immunity . 61 Christopher Lima (2003): Structure Meets Function . 64 Laura Johnston (2004): How Life Shapes Up . .67 Senthil Muthuswamy (2004): Tackling Cancer in Three Dimensions . .70 David Sabatini (2004): Fueling Cell Growth . .73 David Tuveson (2004): Decoding a Cryptic Cancer . 76 Hilary Coller (2005): When Cells Sleep . .79 Diana Bautista (2010): An Itch for Knowledge . .82 David Prober (2010): Sleeping Like the Fishes .
    [Show full text]